BREAKING NEWS - Business: Roche continues to expand production in the US
The latest news.
Roche's US subsidiary Genentech is investing around $750 million in a new facility for filling and finishing medical products at its campus in Hillsboro, Oregon. The facility will provide new device filling capacities and support Roche and Genentech's future pipeline of innovative medicines. This is part of Roche's plans to invest $50 billion in the US, announced in April 2025, which also includes a new production site in Holly Springs, North Carolina, set to start operations in 2029 with 500 employees.
The new Hillsboro facility will support the production of advanced drug delivery devices, including prefilled syringes and autoinjectors.
Written by urgent.news from NZZ Wirtschaft's report — not a translation of it. Machine-written — may contain errors; check the original before relying on it.
